FDA Mulls Which EU Inspections To Skip Under EU MRA
Executive Summary
As US FDA sets its FY 2018 inspection priorities, it is considering whether there are recent or upcoming inspections by inspectorates in eight European countries recognized under a US/EU mutual recognition agreement that it could rely on instead, agency official says. Over time, FDA could rely more on EU inspection priorities.
You may also be interested in...
Inspection Data Reveals US/EU Mutual Recognition Agreement's Impact On China and India
The agreement reached in the early days of the Trump administration has been putting China and India drug manufacturing in the crosshairs of the world’s leading pharmaceutical inspectorates.
FDA Approves Four More Member States For US-EU Inspections MRA
The landmark mutual recognition agreement is now operational between 12 EU member states and the US Food and Drug Administration.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.